Evidence map›Paper›PMID 35203877›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Evaluation of Bi-Lateral Co-Infections and Antibiotic Resistance Rates among COVID-19 Patients.

Naveed Ahmed, Madiha Khan, Waqas Saleem, Mohmed Isaqali Karobari, Roshan Noor Mohamed, Artak Heboyan, Ali A Rabaan, Abbas Al Mutair, Saad Alhumaid, Salman A Alsadiq and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Co-Infection of SARS-CoV-2 andDiagnostics (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Life (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Antibacterial Activity ofInfection and drug resistance · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 7 countries.

Naveed AhmedDepartment of Microbiology, Faculty of Life Sciences, University of Central Punjab, Lahore 54000, Pakistan.ORCID 0000-0003-1504-1705
Madiha KhanDepartment of Microbiology, Faculty of Life Sciences, University of Central Punjab, Lahore 54000, Pakistan.
Waqas SaleemDepartment of Microbiology, Faculty of Life Sciences, University of Central Punjab, Lahore 54000, Pakistan.
Mohmed Isaqali KarobariCenter for Transdisciplinary Research (CFTR), Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences University, Chennai 600077, Tamil Nadu, India.ORCID 0000-0002-0313-9695
Roshan Noor MohamedDepartment of Pediatric Dentistry, Faculty of Dentistry, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Artak HeboyanDepartment of Prosthodontics, Faculty of Stomatology, Yerevan State Medical University after Mkhitar Heratsi, Str. Koryun 2, Yerevan 0025, Armenia.ORCID 0000-0001-8329-3205
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia.ORCID 0000-0002-6774-9847
Abbas Al MutairSchool of Nursing, Wollongong University, Wollongong, NSW 2522, Australia.
Saad AlhumaidAdministration of Pharmaceutical Care, Al-Ahsa Health Cluster, Ministry of Health, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-4552-4513
Salman A AlsadiqHome Health Care Department, Ras Tanurah Hospital, Ras Tanurah 32817, Saudi Arabia.
Ahmed S BueidMicrobiology Laboratory, King Faisal General Hospital, Al-Ahsa 31982, Saudi Arabia.
Eman Y SantaliDepartment of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Jeehan H AlestadImmunology and Infectious Microbiology, Glasgow G1 1XQ, UK.
University of Central Punjab · PKTaif University · SAAlfaisal University · SAKing Faisal University · SAMinistry of Health · MMUniversity of Puthisastra · KHUniversity of Wollongong · AUYerevan State Medical University · AM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to the pathogenesis of SARS-CoV-2, bacterial co-infection plays an essential role in the incidence and progression of SARS-CoV-2 infections by increasing the severity of infection, as well as increasing disease symptoms, death rate and antimicrobial resistance (AMR). The current study was conducted in a tertiary-care hospital in Lahore, Pakistan, among hospitalized COVID-19 patients to see the prevalence of bacterial co-infections and the AMR rates among different isolated bacteria. Clinical samples for the laboratory diagnosis were collected from 1165 hospitalized COVID-19 patients, of which 423 were found to be positive for various bacterial infections. Most of the isolated bacteria were Gram-negative rods (

Indexed as

antimicrobial resistanceantimicrobial stewardshipco-infectionsCOVID-19hospital-acquired infectionsSARS-CoV-2

Identifiers

PMID35203877
PMCPMC8868529
OpenAlexW4213160076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.